MedPath

Effects of delta-tocotrienol, resveratrol and vitamin D supplementation mixture on biochemical markers in diabetic patients

Phase 4
Recruiting
Conditions
Type 2 Diabetes mellitus
Registration Number
SLCTR/2018/019
Lead Sponsor
Higher Education Commission (HEC) Pakistan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

1. Pakistani male and female patients 18-70 years of age.
2. Patients of diabetes mellitus type 2 having HbA1C 7-12 %
3. Taking oral hypoglycemic agent for at least one year.
4. Duration of diabetes > 5 years

Exclusion Criteria

1. Acute illness
2. Chronic illness including chronic liver disease, Seropositive for HIV, Hepatitis B or Hepatitis C
3. Chronic kidney diseases
4. Uncontrolled hypertension. SBP of >180 mmHg and DBP >110 mmHg
5. Thyroid disorders (TSH <0.3 or >5.5 µIU/mL) or thyroid malignancy
6. BMI more than 35 kg/m2
7. Medical history/clinical evidence of familial hyperlipidemic disorder.
8. Pregnant or lactating women
9. Taking insulin, statins, anti-inflammatory drugs, vitamin E and vitamin D regularly or in the last 4 weeks
10. Unable to give informed consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.